Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Long-Term Investments (2020 - 2024)

Historic Long-Term Investments for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2024 value amounting to $35000.0.

  • Burning Rock Biotech's Long-Term Investments fell 3396.23% to $35000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $35000.0, marking a year-over-year decrease of 3396.23%. This contributed to the annual value of $47000.0 for FY2023, which is 5300.0% down from last year.
  • As of Q3 2024, Burning Rock Biotech's Long-Term Investments stood at $35000.0, which was down 3396.23% from $34000.0 recorded in Q2 2024.
  • In the past 5 years, Burning Rock Biotech's Long-Term Investments ranged from a high of $250000.0 in Q2 2020 and a low of $34000.0 during Q1 2024
  • Moreover, its 5-year median value for Long-Term Investments was $104500.0 (2022), whereas its average is $121722.2.
  • Per our database at Business Quant, Burning Rock Biotech's Long-Term Investments tumbled by 2200.0% in 2021 and then tumbled by 6091.95% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Long-Term Investments (Quarter) stood at $217000.0 in 2020, then tumbled by 34.1% to $143000.0 in 2021, then plummeted by 30.07% to $100000.0 in 2022, then crashed by 53.0% to $47000.0 in 2023, then fell by 25.53% to $35000.0 in 2024.
  • Its last three reported values are $35000.0 in Q3 2024, $34000.0 for Q2 2024, and $34000.0 during Q1 2024.